|
Stock-Based Compensation (Tables)
|
9 Months Ended |
12 Months Ended |
|
Mar. 31, 2014
|
Jun. 30, 2013
|
| Share-Based Compensation [Abstract] |
|
|
| Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] |
|
AntriaBio has computed the fair value of all options granted during the year ended June 30, 2013 using the following assumptions:
| Expected volatility | | 106% - 111% | |
| Risk free interest rate | | 0.88% - 1.05% | |
| Expected term (years) | | 5 | |
| Dividend yield | | 0 | % |
|
| Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] |
Stock option activity is as follows:
| | | | | | Weighted | | Weighted Average | |
| | | Number of | | Average | | Remaining | |
| | | Options | | Exercise Price | | Contractual Life | |
| Outstanding, June 30, 2012 | | | - | | $ | - | | | - | |
| Granted | | | 1,508,334 | | $ | 4.50 | | | | |
| Outstanding, June 30, 2013 | | | 1,508,334 | | $ | 4.50 | | | 4.6 | |
| Granted | | | 2,680,000 | | $ | 3.12 | | | | |
| Outstanding, March 31, 2014 | | | 4,188,334 | | $ | 3.62 | | | 4.6 | |
| | | | | | | | | | | |
| Exercisable at March 31, 2014 | | | 1,174,190 | | $ | 4.50 | | | 3.9 | |
|
Stock option activity is as follows:
| | | | | Weighted | | Weighted Average | |
| | | Number of | | Average | | Remaining | |
| | | Options | | Exercise Price | | Contractual Life | |
| Outstanding, June 30, 2012 | | | - | | $ | - | | | - | |
| Granted | | | 1,508,334 | | $ | 4.50 | | | | |
| Outstanding, June 30, 2013 | | | 1,508,334 | | $ | 4.50 | | | 4.6 | |
| | | | | | | | | | | |
| Exercisable at June 30, 2013 | | | 1,035,649 | | $ | 4.50 | | | 4.6 | |
|
| Schedule Of Warrants Issued To Agents Activity [Table Text Block] |
AntriaBio issued warrants to agents and note holders in conjunction with the closing of its convertible notes payable as follows:
| | | | | | Weighted | | Weighted Average | |
| | | Number of | | Average | | Remaining | |
| | | Warrants | | Exercise Price | | Contractual Life | |
| Outstanding, June 30, 2012 | | | - | | $ | - | | | - | |
| Warrants issued to placement agents | | | 41,424 | | $ | 1.98 | | | | |
| Warrants issued to placement agent | | | 233,334 | | $ | 1.50 | | | | |
| Warrants issued to placement agent | | | 18,334 | | $ | 4.95 | | | | |
| Outstanding, June 30, 2013 | | | 293,092 | | $ | 1.80 | | | 4.1 | |
| Warrants issued to note holders | | | 225,259 | | $ | 1.89 | | | | |
| Warrants issued to note holders | | | 3,657,205 | | $ | 2.04 | | | | |
| Warrants issued to related party | | | 39,117 | | $ | 7.50 | | | | |
| Warrants issued in private placement | | | 3,716,522 | | $ | 2.34 | | | | |
| Outstanding, March 31, 2014 | | | 7,931,195 | | $ | 2.19 | | | 3.0 | |
|
AntriaBio issued warrants to agents in conjunction with the closing of its convertible notes payable as follows:
| | | | | Weighted | | Weighted Average | |
| | | Number of | | Average | | Remaining | |
| | | Warrants | | Exercise Price | | Contractual Life | |
| Outstanding, June 30, 2012 | | | - | | $ | - | | | - | |
| Warrants issued to placement agents | | | 41,424 | | $ | 1.98 | | | | |
| Warrants issued to placement agent | | | 233,334 | | $ | - | | | | |
| Warrants issued to placement agent | | | 18,334 | | $ | 5.10 | | | | |
| Outstanding, June 30, 2013 | | | 293,092 | | $ | 1.86 | | | 4.1 | |
|
| Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block] |
Significant assumptions were as follows:
| Expected volatility | | 93% - 97% | |
| Risk free interest rate | | 0.78% - 1.46% | |
| Warrant term (years) | | 3 - 5 | |
| Dividend yield | | 0 | % |
|
Significant assumptions were as follows:
| Expected volatility | | 104% - 111% | |
| Risk free interest rate | | 0.88% - 1.41% | |
| Expected term (years) | | 4.1 - 5 | |
| Dividend yield | | 0 | % |
|